News of Note—Sanofi's Dengvaxia, HPV vaccine and more

newspaper
(Pixabay)

Here is some other vaccine news of note for the week.

> Dengvaxia's safety scandal in the Philippines lowered confidence in vaccines overall in the country. Release

> A study found that teenage girls are not more likely to engage in risky sexual behavior if they receive the HPV vaccine. Newsweek article

> Inovio Pharmaceuticals' Ebola vaccine candidate elicited immune responses in a preclinical study. Release

> The Walter Reed Army Institute of Research kicked off an early stage trial of a vaccine candidate against Marburg virus. Release

> Valneva advanced its Chikungunya vaccine candidate to the next stage within a phase 1 trial program. Release

Suggested Articles

GSK has formed several collaborations across the globe that will use its AS03 adjuvant to develop vaccines against the novel coronavirus.

Former FDA Commissioner Scott Gottlieb says 40% of the population needs to be vaccinated to achieve COVID-19 herd immunity.

CanSino Bio, Moderna and a collaboration between Oxford Univeristy and AstraZeneca are frontrunners, but they all face hurdles shared and unique.